decreased body size | female (with Myc2)
decreased body size | female (with Myc3)
female sterile (with Myc2)
female sterile (with Myc3)
female sterile (with MycPG45)
Homozygous females and hemizygous males smaller than wild-type flies. The hair density in dm1 wings is the same, indicating that the cells are of comparable size, indicating that dm1 wings are smaller than wild-type wings because they contain fewer cells. dm1/dmPG45 females produce eggs with a 2-3% hatching rate.
Overt small and slender bristles and body. Mutant flies carrying dmScer\UAS.cSAa under the control of Scer\GAL4sca-537.4 demonstrate a marked increase in the size of the micro- and macrochaetae of the adult cuticle. Mutant flies carrying dmhs.PSA also exhibit rescue of the bristle and body size.
Germ cells and follicle cells are defective, failing to migrate and undergo the transition to columnar epithelium.
Bristles and body small and slender. Viability excellent. Females sterile. Oocyte cyst development abnormal; nurse-cell nuclei swell in stage 7, subsequently becoming pycnotic (King and Burnett, 1957); cuboidal follicle cells covering developing oocyte in stage 8 fail to show normal growth and degenerate rather than becoming columnar (King and Vanoucek, 1960). Chambers degenerate around stage 8; phenotype of homozygous dm less severe than that of dm hemizygous with dm- deficiency (King and Vanoucek, 1960). RK1.
Mycdm-1 has lethal | female limited phenotype, suppressible by sisAunspecified
Mycdm-1 has lethal | female limited phenotype, suppressible by scsisB-1
Mycdm-1 has lethal | female limited phenotype, suppressible by run3
Mycdm-1 has decreased body size | recessive phenotype, suppressible by ago[+]/ago1
Mycdm-1 has decreased body size | recessive | female phenotype, suppressible by ago[+]/ago1
Mycdm-1 has female sterile | recessive phenotype, suppressible by ago[+]/ago1
Mycdm-1 has decreased cell number | recessive phenotype, suppressible by ago[+]/ago1
Mycdm-1/Myc[+] is an enhancer of decreased size | adult stage | somatic clone - tissue specific phenotype of Kdm5I1, hidGMR.PG
Mycdm-1/Myc[+] is an enhancer of visible | adult stage | somatic clone - tissue specific phenotype of Kdm5I1, hidGMR.PG
Mycdm-1 is a suppressor | partially of viable phenotype of SxlN.Hsp83.lacZ, SxlfP7B0
Mycdm-1 is a suppressor of visible phenotype of upd1GMR.PB
Mycdm-1/Myc[+] is a non-suppressor of visible | adult stage phenotype of hidGMR.PG
Mycdm-1/Myc[+] is a non-suppressor of decreased size | adult stage phenotype of hidGMR.PG
Egfrf2, Mycdm-1/dm[+] has lethal | dominant | maternal effect | embryonic stage phenotype
Egfrf2, Mycdm-1/dm[+] has abnormal neuroanatomy | dominant | embryonic stage phenotype
HUAS.cMa, Mycdm-1, Scer\GAL4GMR.PF has lethal phenotype
Mycdm-1/Myc[+] is an enhancer of eye | somatic clone - tissue specific phenotype of Kdm5I1, hidGMR.PG
Mycdm-1 is a suppressor of eye phenotype of upd1GMR.PB
Approximately 76% of sisAunspecified dm1 trans-heterozygous female offspring from dm1 fathers mated to sisAunspecified females survive.
Approximately 24% of scsisB-1 dm1 trans-heterozygous female offspring from dm1 fathers mated to scsisB-1 females survive.
All run3 dm1 trans-heterozygous female offspring from dm1 fathers mated to run3 females survive.
Females trans-heterozygous for SxlfP7B0 and dm1 are approximately two-thirds as viable as their dm1/+ siblings.
SxlN.Hsp83.T:Ecol\lacZ females that are trans-heterozygous for SxlfP7B0 and dm1 are two-thirds as viable as their SxlN.Hsp83.T:Ecol\lacZ SxlfP7B0/+ sisters.
Mycdm-1 is rescued by MycUAS.cSAa/Scer\GAL4sca-537.4
Alleles can be ranked in a phenotypic series. Going from weakest to strongest phenotype: dm1 < dmP0 < dmP1.